Recent Finacing
Recent Raise
Alnara Pharmaceuticals develops protein therapeutics for metabolic diseases, advancing liprotamase — a non-porcine pancreatic enzyme replacement therapy for cystic fibrosis — and a pediatric formulation with Cystic Fibrosis Foundation Therapeutics.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors